Telomerase — research review 2

...and the buzz around telomerase in longevity has been immense, largely because it's an enzyme that extends telomeres, those protective caps on our chromosomes.

Exactly. The idea is compelling: telomerase rebuilds telomeres, theoretically offsetting the shortening that happens with each cell division. If telomere shortening contributes to aging, then boosting telomerase sounds like a direct path to longer life.

But when we look at human clinical trials, the picture gets more nuanced than the hype often suggests. For instance, a systematic review in Aging Cell in 2021 looked at various interventions claiming to impact telomere length, and found that human evidence for direct, significant telomere extension by specific compounds often lacks robust, randomized controlled trials.

Right. We see a lot of correlational studies, or in vitro work, but not necessarily the gold standard for causality in humans. And even when telomerase activity is modulated, the impact on healthspan or lifespan in humans is largely still unproven.

What’s really crucial here is differentiating between the mechanism – telomerase extending telomeres – and the outcome in a living human being. A study in PLoS One in 2017 looking at a nutritional intervention claiming telomerase activation, for example, reported no significant change in telomere length in a healthy adult cohort. Null results are incredibly important.

Absolutely. So, while the science of telomeres and telomerase is fascinating, and the pathway is incredibly important to cell biology, human evidence for directly translating telomerase activation into measurable, meaningful longevity benefits for the average person remains largely elusive. We're still very much in the early stages of understanding the full human impact.